V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10310459 | 10039205 | 0 | 0 | 03 | 2018-02-04 | 2018-03-01 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101261562 |
| 10310533 | 10039207 | 1.8 | 114.8 | 03 | 2015-04-28 | 2015-05-15 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100256410 |
| 10310537 | 10039208 | 1.64 | 85.7 | Adjuvant (A) | 2017-07-01 | 2017-08-08 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101114800 |
| 10310557 | 10039209 | 1.8 | 72.15 | null | 2020-08-01 | 2020-11-30 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101569667 |
| 10310561 | 10039210 | 1.64 | 66.6 | null | 2019-10-19 | 2019-11-05 | DABRAFENIB + TRAMETINIB | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100507065 |
| 10310658 | 10039211 | 1.6 | 82 | null | null | 2018-10-16 | Palbociclib | Y | null | PALBOCICLIB | 100780005 |
| 10310666 | 10039212 | 1.81 | 84 | Curative (C) | 2019-08-04 | 2019-08-31 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 101057988 |
| 10310724 | 10039213 | 1.75 | 59.5 | Palliative (P) | 2019-04-07 | 2019-04-22 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 100892745 |
| 10310739 | 10039214 | 1.81 | 70.9 | 03 | 2018-05-05 | 2018-05-19 | Folfirinox | null | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101265584 |
| 10310759 | 10039215 | 1.62 | 91.3 | Palliative (P) | 2019-05-25 | 2019-05-29 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100876879 |
| 10310830 | 10039216 | 1.63 | 88.9 | Adjuvant (A) | 2019-04-10 | 2019-04-16 | CTD Attenuated (Thalidomide 50mg) | 02 | N | CAPECITABINE + GEMCITABINE | 100827551 |
| 10311071 | 10039220 | 1.68 | 51 | Palliative (P) | null | 2019-09-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100142027 |
| 10311214 | 10039222 | 1.7 | 76 | 03 | 2019-12-31 | 2020-01-01 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100183161 |
| 10311223 | 10039223 | null | 125 | Curative (C) | 2016-10-17 | 2016-11-04 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 101265307 |
| 10311238 | 10039224 | 0 | 0 | 03 | 2019-05-28 | 2019-06-28 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100573176 |
| 10311285 | 10039225 | 1.57 | 107 | Adjuvant (A) | 2017-07-22 | 2017-07-23 | null | 02 | N | SUNITINIB | 101599286 |
| 10311342 | 10039226 | 1.61 | 88 | Adjuvant (A) | 2018-10-26 | 2018-11-02 | CHOP R | 02 | N | CHOP R | 100082696 |
| 10311384 | 10039227 | 1.4 | 86.4 | Palliative (P) | 2016-03-10 | 2016-03-15 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101632774 |
| 10311394 | 10039228 | 1.61 | 77 | Palliative (P) | 2019-04-15 | 2019-04-19 | CHOP R - 21 days | 02 | null | CHOP R | 101283823 |
| 10311456 | 10039230 | 1.64 | 69.5 | Neo-adjuvant (N) | 2012-02-07 | 2014-08-27 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 02 | N | DARATUMUMAB | 100251076 |
| 10311493 | 10039231 | 1.59 | 99.2 | Curative (C) | 2021-07-07 | 2021-07-09 | MITOMYCIN | 02 | null | VENETOCLAX | 100310980 |
| 10311523 | 10039233 | 1.41 | 114.8 | 03 | 2018-04-02 | 2018-04-28 | BCG Intravesical | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100773310 |
| 10311569 | 10039234 | 1.65 | 88.9 | Palliative (P) | 2019-08-19 | 2020-08-26 | Avelumab | 02 | N | AVELUMAB | 101519726 |
| 10311603 | 10039235 | 0 | 0 | Adjuvant (A) | 2020-02-03 | 2020-02-07 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101156494 |
| 10311626 | 10039236 | 1.8 | 91.8 | null | 2018-07-16 | 2018-08-11 | FEC + DOCETAXEL | 02 | null | PAZOPANIB | 101748839 |
| 10311653 | 10039237 | 1.62 | 48.4 | null | 2019-10-19 | 2021-01-28 | Venetoclax | 02 | null | CVP R | 101522839 |
| 10311733 | 10039238 | 1.64 | 72.6 | Palliative (P) | 2016-12-30 | 2016-12-31 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101210424 |
| 10311776 | 10039239 | 1.57 | 76.6 | null | 2022-05-18 | 2022-05-19 | BUSULFAN | 02 | null | POMALIDOMIDE | 101293599 |
| 10311921 | 10039240 | 1.7 | 67 | 03 | 2020-02-02 | 2020-02-06 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101261432 |
| 10311935 | 10039241 | 1.67 | 94.3 | Curative (C) | 2018-09-04 | 2018-09-12 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 101566483 |
| 10311956 | 10039242 | 1.78 | 83.1 | Curative (C) | 2000-05-29 | 2020-06-05 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100252385 |
| 10311978 | 10039243 | 1.68 | 68 | null | 2019-05-22 | 2019-05-29 | FLUOROURACIL | N | null | FLUOROURACIL | 100469448 |
| 10311993 | 10039244 | 1.67 | 44.8 | Neo-adjuvant (N) | 2019-12-27 | 2020-01-03 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100885216 |
| 10311997 | 10039245 | 1.71 | 47.6 | null | 2022-03-01 | 2022-03-01 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101855245 |
| 10312013 | 10039246 | 1.62 | 88.2 | 03 | 2018-07-06 | 2018-07-09 | Temozolomide 200mg/m2 | 2 | N | TEMOZOLOMIDE | 101127575 |
| 10312063 | 10039247 | 1.56 | 74 | Palliative (P) | 2015-11-01 | 2015-11-15 | Fluorouracil + Folinic Acid Weekly | Y | N | FLUOROURACIL | 100383608 |
| 10312286 | 10039251 | 1.65 | 70.05 | Neo-adjuvant (N) | 2017-06-01 | 2017-07-18 | IPILIMUMAB + NIVOLUMAB | Y | N | IPILIMUMAB + NIVOLUMAB | 100215492 |
| 10312290 | 10039252 | 1.73 | null | Disease modification (D) | 2018-06-25 | 2018-07-02 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100949859 |
| 10312330 | 10039253 | 1.79 | 66.7 | Adjuvant (A) | 2020-01-21 | 2020-02-10 | Avelumab | null | N | AVELUMAB | 100646726 |
| 10312390 | 10039254 | null | 0 | Palliative (P) | 2019-10-21 | 2019-11-07 | Temozolomide 200mg/m2 | 02 | N | TEMOZOLOMIDE | 101026691 |
| 10312421 | 10039255 | 1.75 | 74.4 | Curative (C) | 2015-05-17 | 2015-05-17 | Palbociclib | N | N | PALBOCICLIB | 101745032 |
| 10312526 | 10039257 | 1.71 | 102.9 | Adjuvant (A) | 2019-08-13 | 2019-08-27 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101672136 |
| 10312600 | 10039259 | 1.54 | 100.2 | Palliative (P) | 2018-11-03 | 2018-12-01 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101066382 |
| 10312647 | 10039260 | 1.69 | 64 | Palliative (P) | 2016-09-06 | 2016-09-18 | Palbociclib | 02 | null | PALBOCICLIB | 101066437 |
| 10312651 | 10039261 | 1.82 | 104.7 | Palliative (P) | 2019-04-26 | 2019-05-05 | FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100691659 |
| 10312783 | 10039265 | 1.76 | 90.9 | Disease modification (D) | 2018-05-11 | 2018-05-11 | CLADRIBINE | 02 | N | CISPLATIN + VINORELBINE | 101130074 |
| 10312818 | 10039266 | 0 | 0 | 03 | 2019-01-05 | 2019-01-17 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100059240 |
| 10312948 | 10039268 | 1.75 | 68 | 03 | 2015-09-04 | 2015-09-23 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | CYTARABINE | 100037406 |
| 10313051 | 10039271 | 1.66 | 70.8 | null | 2020-09-16 | 2020-10-07 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100137289 |
| 10313054 | 10039272 | 1.78 | 99.5 | Adjuvant (A) | 2018-07-24 | 2018-07-31 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101463948 |